|
|
|
|
|
by _ihaque
1874 days ago
|
|
There are a lot of comments in this thread discussing biotech salaries. They're not universally true. Source: I'm the VP of data science at Recursion, a biotech company focused on drug discovery, so I manage or have visibility into hiring in the domains that most people on this site would likely be interested in. The biotech industry (which is made up of at least three rather different verticals: tools, diagnostics, and therapeutics) is changing quite a bit today. There are certainly companies that have less of a technology or data emphasis or who are still trying to figure out the value those could bring, and those companies are far less likely to pay well in SW/DS roles. There are others that either from their inception or more recently realize the value these approaches can deliver and compensate accordingly. I personally find the new wave of biotech startups that are focused on being hybrids of experimental and computational capabilities extremely exciting (which is why I'm at one) and these are the firms where software and mathematical skill sets are most likely to be valued. You'll probably still make more on Wall Street than you would in biotech. But you don't have to be _badly_ paid in order to work on a meaningful mission. OP is, IMO, correct that biology is entering a phase in which computational skills are a rate-limiting factor in our ability to make advances (note: not _the_ limit -- experiment is still absolutely critical), and it's a super exciting and impactful field to be in. Shameless plug: Recursion is hiring a TON of positions in data science and machine learning, engineering, and elsewhere. Check us out: https://www.recursion.com/careers. (Contact info is in my bio.) |
|
I work in "Wall Street".
My firm sells things to those who want to buy them in a highly regulated marketplace with considerable governmental and self-regulatory oversight.
We do this on behalf of investors who entrust us to use their capital as fiduciaries for their, and their clients, best interests.
We solve challenging problems with cutting edge approaches involving non-trivial technical, statistical, and business considerations.
And we are not paid _poorly_ for our efforts.
Please stop pushing a strawman financial industry narrative that we've no meaningful mission to serve your industry's recruiting needs. I don't poo on biotech to source my hires.
(Of course none of this constitutes financial, or personal, advice.)